STERIS Cash Flow from Financial Activities 2010-2025 | STE

STERIS annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
  • STERIS cash flow from financial activities for the quarter ending March 31, 2025 was $-1.572B, a 1745.8% increase year-over-year.
  • STERIS cash flow from financial activities for the twelve months ending March 31, 2025 was $-5.145B, a 31595.9% decline year-over-year.
  • STERIS annual cash flow from financial activities for 2025 was $-1.572B, a 1745.8% increase from 2024.
  • STERIS annual cash flow from financial activities for 2024 was $-0.085B, a 82.92% decline from 2023.
  • STERIS annual cash flow from financial activities for 2023 was $-0.499B, a 530.56% decline from 2022.
STERIS Annual Cash Flow Financial
(Millions of US $)
2025 $-1,572
2024 $-85
2023 $-499
2022 $116
2021 $346
2020 $-163
2019 $-295
2018 $-356
2017 $-267
2016 $560
2015 $70
2014 $-54
2013 $254
2012 $-88
2011 $-48
2010 $-128
2009 $-28
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $23.490B $5.460B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $191.291B 83.78
Thermo Fisher Scientific (TMO) United States $154.123B 18.64
Edwards Lifesciences (EW) United States $45.878B 30.08
Alcon (ALC) Switzerland $43.312B 29.27
IDEXX Laboratories (IDXX) United States $42.730B 49.11
DexCom (DXCM) United States $33.851B 52.32
IQVIA Holdings (IQV) United States $27.242B 15.26
Mettler-Toledo (MTD) United States $24.618B 29.28
Waters (WAT) United States $20.972B 29.59
SONOVA HOLDING (SONVY) Switzerland $17.819B 0.00
Hologic (HOLX) United States $14.487B 15.74
Sysmex ADR (SSMXY) Japan $10.827B 30.71
Penumbra (PEN) United States $9.931B 77.94
Masimo (MASI) United States $9.120B 33.64
Globus Medical (GMED) United States $7.933B 18.90
Glaukos (GKOS) United States $5.795B 0.00
Teleflex (TFX) United States $5.279B 8.71
TransMedics (TMDX) United States $4.446B 96.65
Integer Holdings (ITGR) United States $4.276B 22.41
PROCEPT BioRobotics (PRCT) United States $3.149B 0.00
LivaNova (LIVN) United Kingdom $2.495B 14.85
Veracyte (VCYT) United States $2.144B 30.09
Nihon Kohden (NHNKY) Japan $2.041B 23.41
Elekta AB (EKTAY) Sweden $1.933B 17.38
Alphatec Holdings (ATEC) United States $1.620B 0.00
Artivion (AORT) United States $1.332B 124.76
Tandem Diabetes Care (TNDM) United States $1.262B 0.00
OPKO Health (OPK) United States $1.047B 0.00
Pulse Biosciences (PLSE) United States $1.014B 0.00
Integra LifeSciences Holdings (IART) United States $0.955B 5.08
SiBone (SIBN) United States $0.785B 0.00
IRadimed (IRMD) United States $0.774B 39.25
Beta Bionics (BBNX) United States $0.653B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.565B 8.78
Mesa Laboratories (MLAB) United States $0.538B 12.62
OrthoPediatrics (KIDS) United States $0.519B 0.00
RxSight (RXST) United States $0.515B 0.00
AxoGen (AXGN) United States $0.478B 0.00
Delcath Systems (DCTH) United States $0.473B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
Semler Scientific (SMLR) United States $0.429B 11.42
AngioDynamics (ANGO) United States $0.397B 0.00
Pacific Biosciences Of California (PACB) United States $0.387B 0.00
Treace Medical Concepts (TMCI) United States $0.362B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
ClearPoint Neuro (CLPT) United States $0.330B 0.00
Alpha Tau Medical (DRTS) Israel $0.253B 0.00
908 Devices (MASS) United States $0.241B 0.00
Tactile Systems Technology (TCMD) United States $0.240B 14.56
Neuronetics (STIM) United States $0.232B 0.00
Sight Sciences (SGHT) United States $0.222B 0.00
Biosig Technologies (BSGM) United States $0.209B 0.00
Inogen (INGN) United States $0.190B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
Rapid Micro Biosystems (RPID) United States $0.157B 0.00
CVRx (CVRX) United States $0.152B 0.00
LENSAR (LNSR) United States $0.150B 0.00
Anteris Technologies Global (AVR) Australia $0.146B 0.00
Accuray (ARAY) United States $0.142B 0.00
Lucid Diagnostics (LUCD) United States $0.127B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.080B 48.60
EnVVeno Medical (NVNO) United States $0.071B 0.00
InspireMD (NSPR) United States $0.070B 0.00
EDAP TMS S.A (EDAP) France $0.062B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Spectral AI (MDAI) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.12